Biologics Safety Testing Market Trends:
The global biologics safety testing market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period. The growth of the global biopharmaceutical safety testing market is driven by factors such as the growth of the biopharmaceutical and biosimilar market, increasing concerns about cell culture contamination, and increasing biopharmaceutical R&D activities and investments.
Get Sample PDF:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=34624144
Key Market Players of Biologics Safety Testing Market:
Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), and Eurofins Scientific (Luxembourg)
CHARLES RIVER LABRATORIES (US)
Charles River is one of the key players in the biologics safety testing market, it is a service and early-stage contract research organization (CRO). The company develops a diverse portfolio of discovery and safety assessment services and provides a suite of products and services to support its clients’ manufacturing activities.
Covid-19 Impact On The Global Biologics Saftey Testing Market
COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic. The World Health Organization (WHO) officially declared the outbreak of COVID-19 a pandemic. A mix of established pharmaceutical and biopharmaceutical companies, along with the players of the Biologics safety testing market, have stepped forward to contribute to worldwide research efforts by providing biologics safety testing for developing safety test kits and testing for treatments and vaccines manufacturing that target the infection caused by the novel Coronavirus.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34624144
Opportunity: Emerging markets offer lucrative opportunities
Countries across APAC are very lucrative markets for the life sciences industry. For example, India is positioning itself as a leading global biopharmaceutical innovation hub through important initiatives such as encouraging Public-Private Partnerships (PPPs) in biopharmaceutical R&D projects. Korea is also making efforts to become a global bio hub, focusing on biosimilars, vaccine production, and stem cell treatment. The government is building a biocluster that will serve as the university's R&D cooperation center. We aim to invest. The Korea Research-Centered Pharmaceutical Industry Association has proposed a 15-year corporate tax exemption or 5-15% reduction in order to attract investors and profitability of multinational biopharmaceutical companies.
Biopharmaceutical and biotechnology companies in such emerging markets invest heavily in research to develop breakthrough molecules. The growing demand for remedial treatments for life-threatening diseases, such as cancer and diabetes, is highlighting the need for drug R&D and thereby the demand for biologics safety testing kits for effective quality testing and control.
Recent Developments
In 2021 Charles River Laboratories, Inc. (US) launched a new detection tool, EndoScan-V, a validated endotoxin detection and measurement software used to generate and report quantitative test data. The software performed the requisite measurements and calculations and created test reports with the convenience of digital signature report approval.
In 2021, Charles River Laboratories, Inc. (US) acquired Cognate BioServices to expand its offerings in cell and gene therapy development, testing, and manufacturing, providing clients with an integrated solution from basic research and discovery through CGMP production.
In 2021, Charles River Laboratories, Inc. (US) partnered with JADE Biomedical to expand its biological testing solutions capabilities geographically and cater to the increasing demand for biologics therapeutics, especially cell and gene therapies. This strategic relationship enabled JADE to expand its current global Good Manufacturing Practice (GMP) product testing operations in Shanghai into a second facility and further build upon its current offering of comprehensive biologics quality management and testing services.
In 2021, Lonza launched the PyroTec PRO Automated Robotic Solution for endotoxin testing. The new PyroWave Reader add-on has been designed specifically for use with the sustainable PyroGene Recombinant Factor C (rFC) Assay.
Speak to our analyst for a discussion on the above findings:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=34624144
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation